Drug – bio-affecting and body treating compositions – Topical sun or radiation screening – or tanning preparations
Reexamination Certificate
2005-10-18
2005-10-18
Nutter, Nathan M. (Department: 1711)
Drug, bio-affecting and body treating compositions
Topical sun or radiation screening, or tanning preparations
C514S183000, C514S210030, C514S211070, C514S222200, C514S222800, C514S277000, C514S430000, C514S449000, C514S475000, C514S506000, C514S579000, C514S663000, C514S665000, C514S667000, C514S668000, C514S670000, C514S706000, C514S716000, C514S723000, C514S762000, C514S763000, C514S764000, C514S765000, C514S766000
Reexamination Certificate
active
06955804
ABSTRACT:
Disclosed are methods and compositions for regulating the melanin content of mammalian melanocytes; regulating pigmentation in mammalian skin, hair, wool or fur; treating or preventing various skin and proliferative disorders; by administration of various compounds, including alcohols, diols and/or triols and their analogues.
REFERENCES:
patent: 3956361 (1976-05-01), Stephen
patent: 4102995 (1978-07-01), Hebborn
patent: 4104203 (1978-08-01), Hall et al.
patent: 4390532 (1983-06-01), Stüttgen et al.
patent: 4528126 (1985-07-01), Bruns et al.
patent: 4647585 (1987-03-01), Loots et al.
patent: 5041485 (1991-08-01), Eichenauer et al.
patent: 5068453 (1991-11-01), Kuwahara et al.
patent: 5130136 (1992-07-01), Shono et al.
patent: 5190978 (1993-03-01), Nakamura et al.
patent: 5232688 (1993-08-01), Ziegler et al.
patent: 5302378 (1994-04-01), Crotty et al.
patent: 5352440 (1994-10-01), Gilchrest et al.
patent: 5414019 (1995-05-01), Gould et al.
patent: 5525635 (1996-06-01), Moberg
patent: 5532001 (1996-07-01), Gilchrest et al.
patent: 5554359 (1996-09-01), Fuller
patent: 5574195 (1996-11-01), Chastain et al.
patent: 5587402 (1996-12-01), Gould et al.
patent: 5591423 (1997-01-01), Fuller
patent: 5602184 (1997-02-01), Myers et al.
patent: 5626839 (1997-05-01), Scales-Medeiros
patent: 5698184 (1997-12-01), Pickart
patent: 5700450 (1997-12-01), Gilchrest et al.
patent: 5990177 (1999-11-01), Brown
patent: 6214888 (2001-04-01), Ren et al.
patent: 6231837 (2001-05-01), Stroud et al.
patent: 6267948 (2001-07-01), Ren et al.
patent: 6294585 (2001-09-01), Brown
patent: 6623724 (2003-09-01), Brown et al.
patent: 0 643 113 (1995-03-01), None
patent: 1 200 862 (1970-08-01), None
patent: WO 87 04617 (1987-07-01), None
patent: WO 89 00853 (1989-02-01), None
patent: WO 96 09810 (1996-04-01), None
patent: WO 96/26711 (1996-09-01), None
patent: WO 97 03170 (1997-01-01), None
patent: WO 97 30692 (1997-08-01), None
patent: WO 98/11882 (1998-03-01), None
patent: WO 98 55085 (1998-12-01), None
patent: WO 99 08654 (1999-02-01), None
Krieger, H. “Arzneimittelforschung an Norbornan-Derivaten 2. Mitteilung,” Arzneimittel-Forschung, vol. 18, No. 3 1968, pp. 324-330, XP009020785, with attached English translation of Section 8.
Suematsu et al., “Gaseous monoxides: a new class of microvascular regulator in the liver,”Cardiovascular Research, 32: 679-686, 1996.
Anwer et al., “Essential Role of Sodium and Chloride for Theophylline-Induced Choleresis in the Isolated Perfused Rat Liver,”Proceedings of the Society for Experimental Biology and Medicine, 176:70-76, 1984.
Barnhart et al., “Characteristics Common to Choleretic Increments of Bile Induced by Theophylline, Glucagon and SQ-20009 in the dog,”Proceedings of the Society for Experimental Biology and Medicine, 150:591-596, 1975.
Barrera et al., “Effect of Epomediol on the ATPase and Adenylate Cyclase Activities in Plasmamembranes Isolated from Rat Liver,”Pharmacological Research Communications, 16:1133-1140, 1984.
Cho, Won Kyoo, “Role of the Neuropeptide, Bombesin, in Bile Secretion,”Yale Journal of Biology and Medicine, 70:409-416, 1997.
Francis et al., “cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway,”Journal of Hepatology, 41:528-537, 2004.
Kaminski et al., “The Effects of Prostacyclin on Canine Hepatic Bile Flow,”Hepatology, 4:644-650, 1984.
Larsen et al., “The effect of glucagons, dibutyrylic cyclic AMP and theophylline on bile production in the cat,”Acta Physiol. Scand., 106:23-27, 1979.
Lenzen et al., “Secretin stimulates bile ductular secretory activity through the cAMP system,”Amer. J. Physiol., 263:G527-532, 1992.
Lenzen et al., “Glucagon induces biliary protein excretion in guinea pigs,”Amer. J. Physiol., 264:G961-G966, 1993.
LeSage et al., “α-1 Adrenergic Receptor Agonists Modulate Ductal Secretion of BDL Rats via Ca2+—and PKC-Dependent Stimulation of cAMP,”Hepatology, 40:1116-1127, 2004.
Levine et al., “Cyclic AMP in Secretin Choleresis: Evidence for a regulatory role in man and baboons but not in dogs,”Gastroenterology, 70:537-544, 1976.
McGill, et al., “Secretin activates C1-channels in bile duct epithelial cells through a cAMP-dependent mechanism”Amer. J. Physiol., 266:G731-G736, 1994.
Myers et al., “cGMP stimulates bile acid-independent bile formation and biliary bicarbonate excretion,”Amer. J. Physiol., 270:G418-G424, 1996.
St-Pierre et al., “Stimulation of Bile Acid Independent Bile Flow with Bromo-Cyclic Guanosine Monophosphate,”Hepatology, 24:1487-1491, 1996.
Taniai et al., “Endothelin B Receptor-Mediated Protection Against Anoxia-Reoxygenation Injury in Perfused Rat Liver: Nitric Oxide-Dependent and -Independent Mechanisms,”Hepatology, 33:894-901, 2001.
Trauner et al., “Nitric Oxide Donors Stimulate Bile Flow and Glutathione Disulfide Excretion Independent of Guanosine3′, 5′-Cyclic Monophosphate in the Isolated Perfused Rat Liver,”Hepatology, 25:263-269, 1997.
Trauner et al., “Nitric Oxide and Guanosine 3′, 5′-Cyclic Monophosphate Stimulate Bile Secretion in Isolated Rat Hepatocyte Couplets, But Not in Isolated Bile Duct Units,”Hepatology, 28:1621-1628, 1998.
Adnot et al., “Pulmonary hypertension: NO therapy?,”Thorax, 1996, 51:762-764.
Andersson and Stief, “Neurotransmission and the contraction and relaxation of penile erectile tissues,” 1997,World J. Urol. 15:14-20.
Andersson, K.-E., “Neurotransmitters and neuroreceptors in the lower urinary tract,”Curr. Opin. Obstet. Gynecol., 1996, 8:361-365.
Baron, A., “Insulin and the Vasculature—Old Actors, New Roles,”J. Investig. Med., 1996, 44:406-412.
Brann et al., “Gaseous Transmitters and Neuroendocrine Regulation,”Neuroendocrinology, 1997, 65:385-395.
Carter et al., “Nitric oxide production is intensely and persistently increased in tissue by thermal injury,”Biochem. J., 1994, 304(Pt 1):201-04.
Cooke and Dzau, “Nitric Oxide Synthase: Role in the Genesis of Vascular Disease,”Annu. Ref. Med., 48:489-509, 1997.
Dawson et al., “Nitric Oxide Actions in Neurochemistery,”Neurochem. Int., 1996, 29:97-110.
Gorfine, S., “Treatment of Benign Anal Disease with Topical Nitroglycerin,”Dis. Colon Rectum, 1995, 38:453-456.
Kone, et al., “Biosynthesis and homeostatic roles of nitric oxide in the normal kidney,”Am. J. Physiol., 1997, 10:F561-578.
Lahera, et al., “Nitric Oxide, the Kidney, and Hypertension,”Am. J. Hypertens. 10:129-140, 1997.
Marriott and Higenbottam, “The role of nitric oxide in respiratory disease,” 1997,Schweiz Med. Wochenschr. 127:709-714 (abstract).
Mashimo et al., “Effects of Vasodilators Guanethidine, Nicardipine, Nitroglycerin, and Prostaglandin E1on Primary Afferent Nociceptors in Humans,”J. Clin. Pharmacol., 1997, 37:330-335.
Murrell et al., “Modulation of tendon healing by nitric oxide”Inflamm. Res., 1997, 46:19-27.
Packard et al., “Pathogenesis of Posttraumatic Headache and Migraine: A Common Headache Pathway?”Headache, 1997, Mar. 37:142-152.
Pipili-Synetos et al., “Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate,”Br. J. Pharmacol., 1995, 116:1829-1834.
Rishi et al, “Gastrointestinal Protection by NO from NSAIDs Induced Injury,”Indian J. Physiol. Pharmacol., 1996, 40:377-379.
Rubbo et al, “Nitric Oxide Regulation of Tissue Free Radical Injury,”Chem. Res. Toxicol., 1996, 9:809-820.
Samdani et al, “Nitric Oxide Synthase in Models of Focal Ischemia,”Stroke, 1997, 28:1283-1288.
Schaffer et al., “Nitric Oxide Regulates Wound Healing
Brown David A.
Khorlin Alexander A.
Lesiak Krystyna
Ren Wu Yun
Applied Genetics Incorporated Dematics
Klee Maurice M.
Nutter Nathan M.
LandOfFree
Dermatological compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dermatological compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dermatological compositions and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3452798